Letermovir Prophylaxis in Solid Organ Transplant - CMV Breakthrough and Tacrolimus Drug Interaction

被引：0
|
作者：
Winstead, R. [1 ]
Kumar, D. [1 ]
Brown, A. [1 ]
Yakubu, I. [1 ]
Song, C. [1 ]
Thacker, L. [2 ]
Gupta, G. [1 ]
机构：
[1] Virginia Commonwealth Univ Hlth, Richmond, VA USA
[2] Virginia Commonwealth Univ, Richmond, VA USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2021年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
821
引用
收藏
页码：844 / 844
页数：1
相关论文
共 50 条
  • [21] Breakthrough cytomegalovirus pneumonia in hematopoietic stem cell transplant recipient on letermovir prophylaxis
    Knoll, Bettina M.
    Seiter, Karen
    Phillips, Adrienne
    Soave, Rosemary
    BONE MARROW TRANSPLANTATION, 2019, 54 (06) : 911 - 912
  • [22] Breakthrough cytomegalovirus pneumonia in hematopoietic stem cell transplant recipient on letermovir prophylaxis
    Bettina M. Knoll
    Karen Seiter
    Adrienne Phillips
    Rosemary Soave
    Bone Marrow Transplantation, 2019, 54 : 911 - 912
  • [23] Drug-drug interaction between isavuconazole and tacrolimus in solid organ transplant recipients, which magnitude in clinical practice?
    Le Bouedec, D.
    Franck, B.
    Boglione-Kerrien, C.
    Verdier, M. C.
    Lemaitre, F.
    Tron, C.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2023, 37 : 148 - 148
  • [24] The UW Experience: Feasibility of De Novo Letermovir for Primary Prophylaxis After Abdominal Solid Organ Transplant
    Descourouez, Jillian L.
    Kleiboeker, Hanna
    Saddler, Christopher M.
    Smith, Jeannina A.
    Rice, John P.
    Mandelbrot, Didier A.
    Odorico, Jon S.
    Jorgenson, Margaret R.
    ANNALS OF PHARMACOTHERAPY, 2025,
  • [25] Efficacy and Pharmacoeconomic Impact of Letermovir for CMV Prophylaxis in Allogeneic Hematopoietic Cell Transplant Recipients
    Merchant, Shelby Lorraine
    Gatwood, Katie S.
    Satyanarayana, Gowri
    Byrne, Michael T.
    Kassim, Adetola A.
    Jagasia, Madan
    Savani, Bipin
    Engelhardt, Brian G.
    Culos, Kathryn Ann A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [26] Letermovir Prophylaxis in Patients at High Risk for CMV Disease Following Hematopoietic Cell Transplant
    Nguyen, Isabelle T.
    Johnsrud, Joyce J.
    Brown, Janice
    Domingo, Walter
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S347 - S348
  • [27] CMV colitis in solid organ transplant patients
    Yildiz, Ozan
    Arslan, Hande
    Ozgun, Gonca
    Suna, Nuredtin
    Yilmaz, Ozlem
    Karakaya, Emre
    Haberal, Mehmet A.
    TRANSPLANTATION, 2024, 108 (9S)
  • [28] CMV retinitis in solid organ transplant patients
    Lemley, CA
    Limaye, AP
    Chuang, EL
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U599 - U599
  • [29] CMV colitis in solid organ transplant patients
    Yildiz, Ozan
    Arslan, Hande
    Ozgun, Gonca
    Suna, Nuredtin
    Yilmaz, Ozlem
    Karakaya, Emre
    Haberal, Mehmet A.
    TRANSPLANTATION, 2024, 108 (09) : 470 - 470
  • [30] Pharmacokinetic and pharmacodynamic assessement of valganciclovir in the prophylaxis and treatment of CMV disease in solid organ transplant patients
    Manuel, O.
    Perrottet, N.
    Lamoth, F.
    Venetz, J-P
    Decosterd, L. A.
    Buclin, T.
    Pascual, M.
    Meylan, P.
    SWISS MEDICAL WEEKLY, 2007, 137 : 9S - 9S
12345